BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Restricted Cash of $1.74 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-12
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $164.00K, a 310.00% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was -$2.23M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $2.56M, a 3.98% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $1.25M, a 254.67% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2017 was $1.74M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2016 was -$66.00K, a 104.51% decline from fiscal 2015.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2015 was $1.46M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2014 was -$1.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$2.07M derived: sum of 2 quarters · filed 2018-03-12 | $488.00K derived: sum of 3 quarters · filed 2018-03-12 | $1.74M 10-K · filed 2018-03-12 |
| 2017-09-30 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $324.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.58M 10-Q · filed 2017-11-08 | $1.62M derived: sum of 4 quarters · filed 2018-03-12 |
| 2017-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.81M 10-Q · filed 2017-08-08 | $3.85M derived: sum of 3 quarters · filed 2018-03-12 | $931.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2017-03-31 | $1.25M 10-Q · filed 2017-05-08 | $1.29M derived: sum of 2 quarters · filed 2018-03-12 | -$1.63M derived: sum of 3 quarters · filed 2018-03-12 | $833.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$2.88M derived: sum of 2 quarters · filed 2018-03-12 | -$419.00K derived: sum of 3 quarters · filed 2018-03-12 | -$66.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$459.00K derived: sum of 2 quarters · filed 2017-11-08 | -$106.00K 10-Q · filed 2017-11-08 | -$116.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.81M 10-Q · filed 2017-08-08 | $2.80M derived: sum of 3 quarters · filed 2018-03-12 | $2.86M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $353.00K 10-Q · filed 2017-05-08 | $343.00K derived: sum of 2 quarters · filed 2018-03-12 | $396.00K derived: sum of 3 quarters · filed 2018-03-12 | -$672.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $43.00K derived: sum of 2 quarters · filed 2018-03-12 | -$1.02M derived: sum of 3 quarters · filed 2018-03-12 | $1.46M 10-K · filed 2018-03-12 |
| 2015-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$1.01M derived: sum of 2 quarters · filed 2016-11-08 | $1.47M 10-Q · filed 2016-11-08 | $1.47M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.42M 10-Q · filed 2016-08-08 | $1.42M derived: sum of 3 quarters · filed 2017-02-27 | $1.42M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $2.49M 10-Q · filed 2016-05-09 | $2.49M derived: sum of 2 quarters · filed 2017-02-27 | $2.49M derived: sum of 3 quarters · filed 2017-02-27 | $2.49M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $0.00 derived: sum of 3 quarters · filed 2017-02-27 | -$1.00K 10-K · filed 2017-02-27 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | -$1.00K 10-Q · filed 2015-11-06 | $0.00 derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$1.00K 10-Q · filed 2015-08-07 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | -$1.98M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$1.00K 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | -$1.98M derived: sum of 3 quarters · filed 2016-02-26 | -$466.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$1.98M derived: sum of 2 quarters · filed 2016-02-26 | -$465.00K derived: sum of 3 quarters · filed 2016-02-26 | -$157.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$466.00K derived: sum of 2 quarters · filed 2014-11-07 | -$158.00K 10-Q · filed 2014-11-07 | -$150.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $1.82M 10-Q · filed 2014-08-08 | $1.83M derived: sum of 3 quarters · filed 2015-03-02 | -$101.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $308.00K 10-Q · filed 2014-05-09 | $316.00K derived: sum of 2 quarters · filed 2015-03-02 | -$1.61M derived: sum of 3 quarters · filed 2015-03-02 | -$339.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$1.92M derived: sum of 2 quarters · filed 2015-03-02 | -$647.00K derived: sum of 3 quarters · filed 2015-03-02 | -$317.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$655.00K derived: sum of 2 quarters · filed 2013-11-08 | -$325.00K 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.60M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $330.00K 10-Q · filed 2013-05-09 | |||
| 2011-06-30 | $791.00K 10-Q · filed 2012-08-08 | |||
| 2009-12-31 | $625.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |